A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche’s petrelintide shows promise in Phase II obesity trial - The Pharma Letter
Roche’s petrelintide shows promise in Phase II obesity trial - The Pharma Letter
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug - Fierce Biotech
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug - Fierce Biotech
Roche, stakeholders urge Africa to treat health as economic investment - Realnews Magazine
Roche, stakeholders urge Africa to treat health as economic investment - Realnews Magazine
Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech
Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition
Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition
Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech
Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech
AI Drug Discovery: How Roche Accelerates Health Innovation - AI Magazine
AI Drug Discovery: How Roche Accelerates Health Innovation - AI Magazine
Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News
Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News
Roche halts development of Enspryng in Duchenne muscular dystrophy - Fierce Pharma
Roche halts development of Enspryng in Duchenne muscular dystrophy - Fierce Pharma
Roche to stop work on bone health treatment for Duchenne - Endpoints News
Roche to stop work on bone health treatment for Duchenne - Endpoints News
Roche taps Aussie oncologist to lead research—Chutes & Ladders - Fierce Biotech
Roche taps Aussie oncologist to lead research—Chutes & Ladders - Fierce Biotech
Clinical Trials - Roche
Clinical Trials - Roche
Roche to end manufacturing of key antibiotic amid EU’s generic woes - Euractiv
Roche to end manufacturing of key antibiotic amid EU’s generic woes - Euractiv
Paragon's latest biotech will try to slow Alzheimer's like Roche - Endpoints News
Paragon's latest biotech will try to slow Alzheimer's like Roche - Endpoints News
Number of Roche Group employees from 2007 to 2025 - Statista
Number of Roche Group employees from 2007 to 2025 - Statista
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page